Cochrane Abstracts
Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis: Cochrane systematic review
Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Recombinant Human Erythropoietin Versus Placebo or No Treatment for the Anaemia of Chronic Kidney Disease in People Not Requiring Dialysis: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433187/all/Recombinant_human_erythropoietin_versus_placebo_or_no_treatment_for_the_anaemia_of_chronic_kidney_disease_in_people_not_requiring_dialysis:_Cochrane_systematic_review. Accessed 06 May 2021.
Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433187/all/Recombinant_human_erythropoietin_versus_placebo_or_no_treatment_for_the_anaemia_of_chronic_kidney_disease_in_people_not_requiring_dialysis:_Cochrane_systematic_review. Accessed May 6, 2021.
Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433187/all/Recombinant_human_erythropoietin_versus_placebo_or_no_treatment_for_the_anaemia_of_chronic_kidney_disease_in_people_not_requiring_dialysis:_Cochrane_systematic_review
Recombinant Human Erythropoietin Versus Placebo or No Treatment for the Anaemia of Chronic Kidney Disease in People Not Requiring Dialysis: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 May 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433187/all/Recombinant_human_erythropoietin_versus_placebo_or_no_treatment_for_the_anaemia_of_chronic_kidney_disease_in_people_not_requiring_dialysis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis: Cochrane systematic review
ID - 433187
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433187/all/Recombinant_human_erythropoietin_versus_placebo_or_no_treatment_for_the_anaemia_of_chronic_kidney_disease_in_people_not_requiring_dialysis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
